Stephen K. Brannan insider trades

Open-market stock purchases and sales by Stephen K. Brannan, Director at Serina Therapeutics, Inc, from SEC Form 4 filings since Feb 14, 2020.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -13%.

Recent trades

DateStockTradeValue
Jul 7, 2026SER Serina Therapeutics, IncBought$2K
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)—
Nov 7, 2025SER Serina Therapeutics, IncBought (not open market)—

Companies traded

  • SER Serina Therapeutics, Inc: 1 buy, last Jul 7, 2026
  • KRTX Karuna Therapeutics, Inc: 53 sales, last Mar 18, 2024

Get free alerts when Stephen K. Brannan files a new trade →